Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the first clinical readout from ...

Discover Guardant Health's FDA breakthroughs & revenue growth! Learn why profitability-focused investors might hold back ...

Cathie Wood’s ARK ETFs have released their daily trade report for Tuesday, 22 July 2025, showcasing a series of strategic buy ...